LEAP: Lifestyle Enhancement for ADHD Program 2

Sponsor
Seattle Children's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04779333
Collaborator
National Institutes of Health (NIH) (NIH), National Center for Complementary and Integrative Health (NCCIH) (NIH)
80
1
2
31.7
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to increase physical activity (PA) in children with ADHD using a novel, family-based intervention that promotes PA within the context of evidence-based behavioral management training (BMT) for caregivers, enhanced with mobile health (mHealth) behavior change strategies.

Primary Objective: To evaluate the primary effects of a 9-week, family-based intervention (Lifestyle Enhancement for ADHD Program - LEAP) to promote PA in young children with ADHD

Secondary: To evaluate secondary effects of the LEAP program on child ADHD symptoms and executive functioning

Condition or Disease Intervention/Treatment Phase
  • Behavioral: LEAP
  • Behavioral: Standard BMT
N/A

Detailed Description

This is a randomized trial comparing the LEAP program to standard BMT for ADHD (without the enhanced focus on health behaviors, mHealth technology, or social media). Specifically, 80 families will be randomized to receive either LEAP or a standard BMT program based on Russell Barkley's Defiant Children intervention manual. Moderators (e.g., child sex, medication, BMI) and mediators (e.g., change in PA) will be analyzed as exploratory outcomes. Hypotheses being tested include: 1) LEAP will be successful in increasing PA in children with ADHD in the short-term and over a year, more so than standard BPT and 2) children randomized to LEAP will exhibit greater and more sustained improvement in clinical outcomes relative to standard BMT. If successful, the R33 phase will inform the development of a larger and longer, confirmatory trial.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Lifestyle Enhancement for ADHD Program (LEAP) Study 2
Actual Study Start Date :
Sep 9, 2020
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: LEAP Group

In addition to the components of the BMT group, the LEAP program includes an emphasis on supporting optimal physical activity, limiting screen time, and encouraging adequate sleep. The child and caregiver are also given a wrist-worn activity tracker and caregivers participate in a motivational Facebook group.

Behavioral: LEAP
LEAP will be delivered through the typical 9 weekly BMT group sessions lasting 90 minutes. Plus wrist worn activity tracker & facebook group.

Active Comparator: BMT Group

The BMT Group will take part in a family-based intervention within the context of evidence-based behavioral management training (BMT) for caregivers. Standard BMT represents the current standard of care for childhood ADHD.

Behavioral: Standard BMT
Weekly BMT groups sessions which follow the Barkley curriculum

Outcome Measures

Primary Outcome Measures

  1. Effects of intervention on Physical Activity [Baseline to 10 weeks]

    Comparing within-subject pre to post activity (MVPA) using accelerometer data

  2. Effects of intervention on Physical Activity [Baseline to 20 weeks]

    Comparing within-subject pre to post activity (MVPA) using accelerometer data

  3. Effects of intervention on Physical Activity [Baseline to 1 year]

    Comparing within-subject pre to post activity (MVPA) using accelerometer data

Secondary Outcome Measures

  1. Effects of LEAP participation on child executive function [Baseline to 10 weeks]

    Evaluate effects of LEAP participation on the child's executive functioning using the parent reported BRIEF-2 measure

  2. Effects of LEAP participation on child executive function [Baseline to 20 weeks]

    Evaluate effects of LEAP participation on the child's executive functioning using the parent reported BRIEF-2 measure

  3. Effects of LEAP participation on child executive function [Baseline to 1 year]

    Evaluate effects of LEAP participation on the child's executive functioning using the parent reported BRIEF-2 measure

  4. Effects of LEAP participation on child ADHD symptoms [Baseline to 10 weeks]

    Evaluate effects of LEAP participation on the child's ADHD symptoms using the Conners-3 Parent Rating Scale

  5. Effects of LEAP participation on child ADHD symptoms [Baseline to 20 weeks]

    Evaluate effects of LEAP participation on the child's ADHD symptoms using the Conners-3 Parent Rating Scale

  6. Effects of LEAP participation on child ADHD symptoms [Baseline to 1 year]

    Evaluate effects of LEAP participation on the child's ADHD symptoms using the Conners-3 Parent Rating Scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria (child):
  • Age 6-10 years

  • ADHD diagnosis

  • CGI-S rating ranging from 4 to 7.

  • Child not wearing a wrist-worn activity tracker more than 50% of days in the past month

Inclusion Criteria (caregiver):
  • One adult custodial caregiver (resides with the child at least 50% of the time) willing to participate in the study and complete baseline/follow-up measures

  • Caregiver able to complete forms in English

  • Caregiver owns a smart phone or similar Garmin compatible mobile device (e.g. iPod Touch) or willing to borrow iPod from study coordinators during the study period

  • Agree to install and share data from the Garmin smart phone app with investigators

Inclusion Criteria (supplementary caregiver):
  • An additional caregiver designated by the participating caregiver who provides care for the participating child on at least one occasion every other week

  • Able to participate in one or more group sessions

  • Able to consent in English

Exclusion Criteria (children):
    • Younger than 6 years old or older than 10 years old
  • Do not meet criteria currently for ADHD diagnosis

  • Meet diagnostic criteria for psychiatric co-morbidities of Autism Spectrum Disorder, Depressive Disorder, Mood Disorder, Psychotic Disorder, or Intellectual Disability (by history)

  • Per caregiver report, engage in >60 min/day of MVPA consistently for at least 5 days per week

  • Any physical or medical restrictions on PA

  • Child currently/previously used a wearable physical activity sensing device at least 50% of days in the past month

Exclusion Criteria (caregiver):
  • Caregiver participated in an evidence-based parent behavior management training program (i.e., Incredible Years, Triple P, PCIT, Barkley's Defiant Child) in the past 24 months.

Exclusion Criteria (supplementary caregiver): none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seattle Children's Research Institute Seattle Washington United States 98145

Sponsors and Collaborators

  • Seattle Children's Hospital
  • National Institutes of Health (NIH)
  • National Center for Complementary and Integrative Health (NCCIH)

Investigators

  • Principal Investigator: Pooja Tandon, MD, Seattle Children's
  • Principal Investigator: Erin Gonzalez, PHD, Seattle Children's

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pooja Tandon, Principal Investigator, Seattle Children's Hospital
ClinicalTrials.gov Identifier:
NCT04779333
Other Study ID Numbers:
  • STUDY00002356
  • R33AT010041
First Posted:
Mar 3, 2021
Last Update Posted:
May 4, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2022